Evidence map›Paper›PMID 19788924›Full record

ReviewNitric oxide : biology and chemistry2010

Mitochondria as metabolizers and targets of nitrite.

Sruti Shiva

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Nitric oxide : biology and chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01725256 phase2terminatednot on this mapstarted 2012, after this paper: background citation

A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)

TypeinterventionalSponsorAires Pharmaceuticals, Inc.Ran2012 to 2014Enrolled29ConditionsPulmonary Arterial HypertensionArmsAIR001 (sodium nitrite inhalation solution)
NCT01725269 phase2terminatednot on this mapstarted 2013, after this paper: background citation

A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension

TypeinterventionalSponsorAires Pharmaceuticals, Inc.Ran2013 to 2014Enrolled17ConditionsPulmonary Arterial HypertensionArmsAIR001
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Biological Mechanisms ofAntioxidants (Basel, Switzerland) · 2021
    Review
  6. Article
  7. Article
  8. Behaviorally-Mediated Entrainment of Whole-Body Metabolic Processes: Conservation and Evolutionary Development of Mitochondrial Respiratory Complexes.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  9. Current approaches to measure nitric oxide in plants.Journal of experimental botany · 2019
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Hypoxia defined as a common culprit/initiation factor in mitochondrial-mediated proinflammatory processes.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Review
  17. Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2015
    Review
  18. Article
  19. The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sruti ShivaDepartment of Pharmacology and Chemical Biology and Vascular Medicine Institute, University of Pittsburgh School of Medicine, 3501 Biomedical Science Tower III, Pittsburgh, PA 15260, USA. sss43@pitt.edu
University of Pittsburgh · US

Funding

Dietary nitrate activation of PPARgamma improves insulin sensitivityRC1DK085852 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, BRUCE ALAN, GLADWIN, MARK T · 2009 to 2010
$999k
NIDDK NIH HHS RC1 DK085852
6 · The paper itself

Abstract

Mitochondrial function is integral to maintaining cellular homeostasis through the production of ATP, the generation of reactive oxygen species (ROS) for signaling, and the regulation of the apoptotic cascade. A number of small molecules, including nitric oxide (NO), are well-characterized regulators of mitochondrial function. Nitrite, an NO metabolite, has recently been described as an endocrine reserve of NO that is reduced to bioavailable NO during hypoxia to mediate physiological responses. Accumulating data suggests that mitochondria may play a role in metabolizing nitrite and that nitrite is a regulator of mitochondrial function. Here, what is known about the interactions of nitrite with the mitochondria is reviewed, with a focus on the role of the mitochondrion as a metabolizer and target of nitrite.

Indexed as

AnimalsHumansMitochondriaNitritesNitrites

Identifiers

PMID19788924
PMCPMC2819587
OpenAlexW1972205940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.